DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksSchließen
Referenz
Cohen DJ, Osnabrugge RL, Magnuson EA. et al; SYNTAX Trial Investigators.
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Circulation 2014;
130 (14) 1146-1157
Für die Inhalte der Internetseiten anderer Anbieter übernehmen wir keine Verantwortung.